Facebook Pixel Code

Samrat Pharmachem Share Price

NSE
BSE

SAMRAT PHARMACHEM

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Samrat Pharmachem along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹322.40 Closed
-0.17₹ -0.55
As on Sep 16, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Samrat Pharmachem Price Performance

Today's LowToday's High
₹322.40₹327.95
₹322.40
52 Weeks' Low52 Weeks' High
₹302.05₹646.00
₹322.40
Open Price
₹322.95
Prev. Close
₹322.95
Volume
531

Over the last 5 years, the share price of Samrat Pharmachem has gained 23.26% CAGR. Over the past year, the corresponding return has been -49.01%.

Samrat Pharmachem’s current P/E of 20.68x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Samrat Pharmachem Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Samrat Pharmachem
1.35-0.28-5.760.61-49.4-34.6223.26
Sun Pharmaceutical Industries
1.08-1.32-2.3-5.58-13.6722.8625.44
Divi's Laboratories
0.84-1.39-6.987.2611.4819.3813.39
Cipla
-0.48-0.533.54.23-6.8814.1815.63
Torrent Pharmaceuticals
-1.63-3.258.6915.52.433.7519.96
Dr. Reddy's Laboratories
0.493.7-0.6413.92-1.1817.097.19
Mankind Pharma
-1.563.979.1718.234.6721.7212.52
Zydus Lifesciences
-0.554.777.7915.71-6.9142.0521.62
Lupin
3.724.155.543.02-9.6648.0414.81
Abbott India
-0.88-4.93-2.462.817.4420.913.41
Alkem Laboratories
3.563.0214.4914.4-11.4120.0114.29
Aurobindo Pharma
3.960.18-1.58-1.88-29.6426.955.6
Glenmark Pharmaceuticals
-2.575.1725.5745.1221.277.3132.95
Laurus Labs
-0.173.4435.5153.9578.5720.127.14
Biocon
-1.06-1.132.147.85-4.17.35-3.86
Anthem Biosciences
1.873.7513.7513.7513.754.392.61
GlaxoSmithKline Pharmaceuticals
-3.13-1.6-15.61.95-1.9624.239.16
Cohance Lifesciences
-0.0210.08-0.3-12.87-14.3728.9621.52
Gland Pharma
6.22.5215.7130.139.43-4.112.12
Ipca Laboratories
-0.22-5.32-3.38-0.34-9.9914.973.52

Over the last one year, Samrat Pharmachem has declined 49.40% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (11.48%), Cipla (-6.88%). From a 5 year perspective, Samrat Pharmachem has outperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).

Samrat Pharmachem Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Samrat Pharmachem Stock Technicals

Moving Average

DaySMAEMA
5319.79322.55
10320.12321.86
20321.31324.29
50342.95334.93
100353.18345.66
200359.36361.46

Samrat Pharmachem Share Holding Pattern

In the latest quarter, Samrat Pharmachem remained same as its previous close in promoter holding, while DII stake increased to 3.24%, FII holding fell to 0.00%, and public shareholding unchanged at 47.67% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Samrat Pharmachem Corporate Actions

Date Time
Announcement
Sep 04, 2025, 7:28 PM ISTSamrat Pharma - Reg. 34 (1) Annual Report.
Sep 04, 2025, 7:20 PM ISTSamrat Pharma - Book Closure: Friday, September 19, 2025 To Thursday, September 25, 2025 (Both Days Inclusive)
Sep 04, 2025, 7:16 PM ISTSamrat Pharma - Record Date - Thursday, September 18, 2025
Sep 04, 2025, 7:09 PM ISTSamrat Pharma - Notice Of 33Rd Annual General Meeting Of Samrat Pharmachem Limited On Thursday, September 25, 2025
Aug 14, 2025, 2:42 AM ISTSamrat Pharma - Un-Audited Financial Results For The Quarter Ended June 30, 2025

About Samrat Pharmachem

Samrat Pharmachem Ltd. is a Public Limited Listed company incorporated on 16/06/1992 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1992PLC017820 and registration number is 017820. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 285.86 Cr. and Equity Capital is Rs. 3.09 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Lalit Mehta
    Chairman & Managing Director
  • Mr. Rajesh Mehta
    Executive Director & CFO
  • Mr. Megh Mehta
    Executive Director
  • Mr. Mahendra Pipalia
    Ind. Non-Executive Director
  • Mr. Samir Kothary
    Ind. Non-Executive Director
  • Ms. Renu Dharod
    Ind. Non-Executive Director

FAQs on Samrat Pharmachem Share Price

What is the share price of Samrat Pharmachem?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Samrat Pharmachem is ₹322.40 as on Sep 16, 2025.

What kind of stock is Samrat Pharmachem?

The Samrat Pharmachem is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Samrat Pharmachem?

The market cap of Samrat Pharmachem is ₹99.61 Cr as on Sep 16, 2025.

What are today's High and Low prices of Samrat Pharmachem?

Today’s highest and lowest price of Samrat Pharmachem are ₹327.95 and ₹322.40.

What are the 52 Week High and 52 Week Low of Samrat Pharmachem?

The 52-week high/low is the highest and lowest price at which Samrat Pharmachem stock has traded in the past 52-week or nearly a year. The 52-week high of Samrat Pharmachem is ₹646.00 and 52-week low of Samrat Pharmachem is ₹302.05 as on Sep 16, 2025.

How has the Samrat Pharmachem performed historically in terms of returns?

The Samrat Pharmachem has shown returns of -0.17% over the past day, -0.28% for the past month, -7.41% over 3 months, -49.01% over 1 year, -34.62% across 3 years, and 23.26% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Samrat Pharmachem?

P/E ratio of and PB ratio of Samrat Pharmachem are 20.68 and 1.39 on Sep 16, 2025. While the company gives a dividend yield of 0.31 per annum.

icon
Market Data